S. Savin

Discovery and structural diversity of the hepatitis C virus NS3/4A serine protease inhibitor series leading to clinical candidate IDX320.

Catherine Caillet, S. Cappelle, M. Liuzzi, 2015, Bioorganic & medicinal chemistry letters.